Literature DB >> 31292863

Reply to Periclou et al.: "Clinical Pharmacokinetics of Atypical Antipsychotics: An Update".

Massimo Carlo Mauri1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31292863     DOI： 10.1007/s40262-019-00796-8

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  4 in total

Review 1.  Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.

Authors:  Massimo Carlo Mauri; Silvia Paletta; Chiara Di Pace; Alessandra Reggiori; Giovanna Cirnigliaro; Isabel Valli; Alfredo Carlo Altamura
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

2.  AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

Authors:  C Hiemke; P Baumann; N Bergemann; A Conca; O Dietmaier; K Egberts; M Fric; M Gerlach; C Greiner; G Gründer; E Haen; U Havemann-Reinecke; E Jaquenoud Sirot; H Kirchherr; G Laux; U C Lutz; T Messer; M J Müller; B Pfuhlmann; B Rambeck; P Riederer; B Schoppek; J Stingl; M Uhr; S Ulrich; R Waschgler; G Zernig
Journal:  Pharmacopsychiatry       Date:  2011-09-27       Impact factor: 5.788

3.  Comment on: "Clinical Pharmacokinetics of Atypical Antipsychotics: An Update".

Authors:  Antonia Periclou; Todd Riccobene; Margit Kapás; István Laszlovszky
Journal:  Clin Pharmacokinet       Date:  2019-09       Impact factor: 6.447

4.  Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment).

Authors:  Tadakatsu Nakamura; Tomoko Kubota; Atsushi Iwakaji; Masayoshi Imada; Margit Kapás; Yasunori Morio
Journal:  Drug Des Devel Ther       Date:  2016-01-14       Impact factor: 4.162
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.